Intrauterine Devices Market Outlook Signals Expansion To $5.08 Billion Through 2030

The intrauterine devices (IUD) market is set for steady progress over the coming years, driven by growing demand for effective and low-maintenance contraceptive solutions. Advances in device design and increasing awareness about family planning programs are playing a crucial role in shaping this market's future. Below, we explore the expected market value, leading players, emerging trends, and key segments that define the IUD industry.

Projected Market Value and Growth Trajectory of the Intrauterine Devices Market
The intrauterine devices market is poised to reach a valuation of $5.08 billion by 2030, expanding at a compound annual growth rate (CAGR) of 4.2%. This steady rise is fueled by several factors such as widespread demand for convenient contraceptive methods requiring minimal upkeep, government-backed family planning initiatives, a growing inclination toward hormone-regulated IUDs, and increasing uptake in developing economies. Additionally, ongoing innovations in IUD materials and designs are propelling market growth. Key trends shaping this expansion include the rising popularity of long-acting contraceptive devices, increased use of hormonal IUDs, preference for reversible birth control options, broader availability of copper-based non-hormonal devices, as well as a stronger focus on patient comfort and safety.

Download a free sample of the intrauterine devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13464&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Top Companies Leading the Intrauterine Devices Market
Several prominent players dominate the IUD market, including Bayer AG, CooperSurgical Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Pregna International Limited, Medicines360 Inc, Eurogine S L, SMB Corporation, and HLL Lifecare Limited. Other notable companies include Injeflex Industria E Commercio Ltd, Corporate Channels India Pvt Ltd, Meril Endo Surgery Pvt Ltd, Krishco Medical Products Pvt Ltd, Prosan International BV, Gima Spa, Laboratoire HRA Pharma SAS, Shandong Weigao Medical Group Co Ltd, Chongqing Zhifei Biological Products Co Ltd, Yantai JiShengYaoXie Co Ltd, TianYi (a China-based IUD manufacturer), Sebela Pharmaceuticals Inc, and Fuji Latex Co Ltd.

Strategic Partnership Highlight: Bayer AG and CrossBay Medical Inc
In November 2023, Bayer AG, a leading German life sciences and pharmaceutical company, entered into a development and option-to-license collaboration with US-based CrossBay Medical Inc. The agreement, for an undisclosed sum, focuses on advancing a next-generation single-handed intrauterine system (IUS) inserter. By incorporating CrossGlide technology, this new inserter aims to enhance insertion comfort, shorten procedure times, and improve the overall experience of placing IUS devices. CrossBay Medical specializes in innovative intrauterine insertion technologies, making this partnership a significant step toward improving IUD delivery systems.

View the full intrauterine devices market report:
https://www.thebusinessresearchcompany.com/report/intrauterine-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends in Intrauterine Device Technology
Innovation remains at the forefront of the intrauterine devices market as companies focus on developing single-hand insertion systems that simplify device placement. These advancements improve provider ergonomics, reduce procedural complexity, and maintain contraceptive reliability. Single-hand insertion delivery systems feature integrated loading and deployment mechanisms that make device insertion more precise and efficient, benefiting busy clinical environments.

For example, in September 2024, CooperSurgical, a US-based women's health and medical device company, rolled out a new FDA-approved single-hand inserter for the Paragard copper intrauterine contraceptive. This redesigned tool incorporates an intuitive mechanism with an integrated loading tip, easing placement without sacrificing Paragard's proven benefits, including over 99% effectiveness, 10 years of contraception, hormone-free formulation, and immediate reversibility.

Segment Breakdown and Market Composition of the Intrauterine Devices Industry
This report categorizes the intrauterine devices market into key segments:
1) Product Type: Hormonal Intrauterine Devices and Copper Intrauterine Devices
2) Age Group: 15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years
3) End User: Hospitals, Gynecology Clinics, Community Healthcare Facilities, and Other Users

Within product types, hormonal IUDs include Levonorgestrel-Releasing devices such as Mirena, Kyleena, and Skyla, as well as other progestin-based IUDs. Copper IUDs are divided into standard copper devices and mini copper versions, catering to different user preferences and medical needs.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.